NO942181L - - Google Patents
Info
- Publication number
- NO942181L NO942181L NO942181A NO942181A NO942181L NO 942181 L NO942181 L NO 942181L NO 942181 A NO942181 A NO 942181A NO 942181 A NO942181 A NO 942181A NO 942181 L NO942181 L NO 942181L
- Authority
- NO
- Norway
- Prior art keywords
- phenyl
- alkyl group
- isomers
- optionally substituted
- formula
- Prior art date
Links
- 206010021143 Hypoxia Diseases 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- RXINFAULMRJDAU-UHFFFAOYSA-N 7h-pyrido[3,4-f][2,1]benzoxazine Chemical class C1=CC2=CC=NC=C2C2=C1NOC=C2 RXINFAULMRJDAU-UHFFFAOYSA-N 0.000 abstract 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 210000004958 brain cell Anatomy 0.000 abstract 1
- 230000006931 brain damage Effects 0.000 abstract 1
- 231100000874 brain damage Toxicity 0.000 abstract 1
- 208000029028 brain injury Diseases 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000007954 hypoxia Effects 0.000 abstract 1
- 230000001146 hypoxic effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU913906A HU209393B (en) | 1991-12-12 | 1991-12-12 | Process for producing new, substituted oxazinoisoquinoline derivates |
| PCT/HU1992/000053 WO1993012118A1 (en) | 1991-12-12 | 1992-12-11 | Novel substituted oxazinoisoquinoline derivatives, pharmaceutical compositions containing them and process for preparing same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO942181L true NO942181L (https=) | 1994-06-10 |
| NO942181D0 NO942181D0 (no) | 1994-06-10 |
Family
ID=10966001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO942181A NO942181D0 (no) | 1991-12-12 | 1994-06-10 | Nye, substituerte oksazinoisokinolinderivater, farmasöytiske preparater inneholdende disse og fremgangsmåte for fremstilling av disse |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5494909A (https=) |
| EP (1) | EP0620820A1 (https=) |
| JP (1) | JPH07501817A (https=) |
| AU (1) | AU3170593A (https=) |
| FI (1) | FI942675A7 (https=) |
| HU (1) | HU209393B (https=) |
| NO (1) | NO942181D0 (https=) |
| TW (1) | TW219364B (https=) |
| WO (1) | WO1993012118A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7128759B2 (en) * | 2003-05-19 | 2006-10-31 | Cook Incorporated | Implantable medical device with constrained expansion |
| WO2007022568A1 (en) | 2005-08-25 | 2007-03-01 | Steven Michael Weiss | Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow |
| CN103651533A (zh) * | 2013-12-30 | 2014-03-26 | 青岛崂乡茶制品有限公司 | 一种新型茶叶种植用农药 |
| CN103651435A (zh) * | 2013-12-30 | 2014-03-26 | 青岛崂乡茶制品有限公司 | 一种环保的茶叶杀虫剂 |
| CN105532682B (zh) * | 2016-02-17 | 2018-03-23 | 陕西先农生物科技有限公司 | 一种含藜芦碱植物源杀虫剂组合物及制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU191301B (en) * | 1984-03-23 | 1987-02-27 | Richter Gedeon Vegyeszeti Gyar Rt,Hu | Process for preparing 1-/hydroxy-methyl/-1,6,7,11b-tetrahydro-2h,4h-/1,3/-oxazino- or -thiazino/4,3-a/isoquinoline -derivatives |
-
1991
- 1991-12-12 HU HU913906A patent/HU209393B/hu not_active IP Right Cessation
-
1992
- 1992-12-11 JP JP5510763A patent/JPH07501817A/ja active Pending
- 1992-12-11 EP EP93900339A patent/EP0620820A1/en not_active Withdrawn
- 1992-12-11 AU AU31705/93A patent/AU3170593A/en not_active Abandoned
- 1992-12-11 US US08/244,736 patent/US5494909A/en not_active Expired - Fee Related
- 1992-12-11 WO PCT/HU1992/000053 patent/WO1993012118A1/en not_active Ceased
- 1992-12-28 TW TW081110477A patent/TW219364B/zh active
-
1994
- 1994-06-07 FI FI942675A patent/FI942675A7/fi not_active Application Discontinuation
- 1994-06-10 NO NO942181A patent/NO942181D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU209393B (en) | 1994-05-30 |
| NO942181D0 (no) | 1994-06-10 |
| US5494909A (en) | 1996-02-27 |
| HUT63427A (en) | 1993-08-30 |
| HU913906D0 (en) | 1992-02-28 |
| EP0620820A1 (en) | 1994-10-26 |
| AU3170593A (en) | 1993-07-19 |
| FI942675A0 (fi) | 1994-06-07 |
| FI942675A7 (fi) | 1994-06-07 |
| WO1993012118A1 (en) | 1993-06-24 |
| TW219364B (https=) | 1994-01-21 |
| JPH07501817A (ja) | 1995-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9701039A0 (en) | Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one. | |
| DE68925223D1 (de) | 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-en-2-carbonsäure-Verbindungen | |
| CO4290427A1 (es) | Preparacion de n-alquilcarboxilatos de piperidinilo 3,4,4- trisustituidos e intermedios | |
| EP0324387A3 (en) | Composition for treatment of ischemic disorder in organs | |
| DK0928788T3 (da) | Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler | |
| NO20002099L (no) | 6,11-bro-erytromycinderivater | |
| CA2356121A1 (en) | Novel propargylether derivatives | |
| NO20001169L (no) | 6,9-bro erythromycinderivater | |
| IL148875A0 (en) | Sulfonyl hydrazide derivatives, their preparation and pharmaceutical compositions containing them | |
| HUT57773A (en) | Process for produicng n-(aminocarbonyl)-carbamates related to physostigmine, as well as pharmaceutical compositions comprising such compounds | |
| NO944933L (no) | Fremgangsmåte for å inhibere sykdomstilstander i brystet | |
| NO942181L (https=) | ||
| CA2060616A1 (en) | Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers | |
| PL312471A1 (en) | Benzene derivatives effective in ischaemia diseases | |
| NO922358L (no) | Tert.-butylfenyl-1-amino-4-hydroksybutanderivater, fremgangsmaate ved deres fremstilling og farmasoeytiske preparaterinneholdende forbindelsene | |
| NO20003431L (no) | Nye metalloproteaseinhibitorer, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NZ315347A (en) | Heterocyclic compounds for treating myocardial ischaemia | |
| RU94037556A (ru) | Новые замещенные оксазиноизохинолиновые производные и способ их приготовления, содержащая их фармацевтическая композиция и способ ингибирования усвоения кальция мозгом млекопитающих | |
| NO995842L (no) | Multicykliske erytromycinderivater | |
| GR3022666T3 (en) | Tri(c1-c6 alkoxy)benzene derivative | |
| NO983452L (no) | FremgangsmÕter for Õ hemme muskuloaponeurotisk fibromatose (desmoide tumorer) | |
| NO944888L (no) | 5-(1,2,4-triazol-1-ylmetyl)-3H-isobenzofuran-1-on derivater, deres fremstilling og anvendelse som aromataseinhibitorer | |
| CA2189652A1 (en) | Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same | |
| YU45994A (sh) | Farmaceutski preparati za prevenciju i/ili tretiranje gastrointenstinalnih oboljenja uključujući ulkus |